-
Canadian Cannabis Producer C21 Launches Share Buyback, Citing Undervalued Stock Price
Wednesday, November 27, 2024 - 12:25pm | 494Vertically integrated cannabis company C21 Investments Inc. (CSE:CXXI) (OTCQX: CXXIF) announced on Tuesday its plan to repurchase approximately 5% of its issued and outstanding common shares as part of a share buyback program, with the intention of canceling the repurchased shares to enhance...
-
Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans
Tuesday, November 26, 2024 - 4:00pm | 515Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), announced on Tuesday developments in cannabis science from Aurora’s research and genetics facility, Aurora Coast. The latest innovations from the Canadian medical cannabis giant include: Aurora | CBD Varius (1g, 510 Cartridge); MedReleaf (...
-
Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability
Monday, November 25, 2024 - 12:57pm | 639Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fourth quarter and full fiscal 2024 financial and operating results on Monday ended Aug. 31. The Montreal-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2...
-
EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions
Friday, November 22, 2024 - 4:30pm | 1007EQUA Specialty Risk Partners, a Canadian-owned insurance brokerage, is taking on one of the cannabis industry's most pervasive challenges: stigma. Through education, advocacy and innovative risk management strategies, EQUA seeks to transform how cannabis businesses access insurance. In an...
-
Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%
Friday, November 22, 2024 - 9:54am | 461Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced its unaudited interim financial results on Thursday for the third quarter ending Sept. 30, 2024. “Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said. "...
-
What's Happening With Canopy Growth: Is It Time To Buy?
Thursday, November 21, 2024 - 8:07pm | 672Canopy Growth Corporation‘s (NASDAQ:CGC) stock has fallen significantly from its recent highs in May 2024. After reaching a peak of $16.41, the stock now trades around $3.93, raising questions about its potential for recovery and long-term investment viability. In this article, we take a...
-
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Wednesday, November 20, 2024 - 6:50pm | 928Canopy Growth Corporation‘s (NASDAQ:CGC) strategy for capturing the U.S. cannabis market was the focal point of a recent fireside chat hosted by Zuanic & Associates. CEO David Klein and CFO Judy Hong provided insights into Canopy USA's (CUSA) growth strategy, financial projections and its...
-
Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores
Friday, November 15, 2024 - 3:42pm | 799Weed Is Not Legal In Florida But Medical Cannabis Retail Footprint Grows Nonetheless RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE:GTII) (OTCQX:GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new...
-
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
Thursday, November 14, 2024 - 1:40pm | 455International medical cannabis company IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial results on Thursday for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). “While the 66%...
-
High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth
Wednesday, November 13, 2024 - 1:24pm | 421High Tide Inc. (NASDAQ:HITI), a leading cannabis retail enterprise, announced today the closing of the final tranche of its $15 million subordinated debt facility. This funding marks the completion of the company's previously disclosed plan to issue secured debentures, providing crucial financial...
-
Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?
Tuesday, November 12, 2024 - 7:35pm | 710Cannabis giants Village Farms, Green Thumb, and Jushi Holdings show distinct strategies for navigating a challenging landscape. In the latest cannabis market analysis from Beacon Securities, three major multi-state operators (MSOs) Village Farms, Green Thumb Industries, and Jushi Holdings...
-
Auxly Cannabis Co.: Q3 Net Revenue Climbs 18% YoY, Adjusted EBITDA Soars
Friday, November 8, 2024 - 1:55pm | 550Cannabis-focused consumer packaged goods company Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) released its financial results on Friday for the three and nine months ended Sept. 30, 2024. “Our continued focus on efficient revenue growth and enhanced profitability has delivered another...
-
Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead
Friday, November 8, 2024 - 9:59am | 712Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results on Friday for the second quarter of fiscal 2025, which ended Sept. 30, 2024. The Canadian cannabis giant reported a 9% year-over-year decrease in net revenue to CA$63 million ($45.4 million). Canopy said excluding net...
-
Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures
Friday, November 1, 2024 - 4:03pm | 859As the cannabis industry maneuvers through financial complexities and regulatory uncertainties, recent updates from Tilray Brands Inc. (NASDAQ:TLRY), High Tide Inc. (NASDAQ:HITI) and Glass House Brands Inc. (OTC:GLASF) offer a clear glimpse into the fiscal health and strategic pivots of these...
-
Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?
Tuesday, October 29, 2024 - 5:24pm | 615Tilray Brands (NASDAQ:TLRY) remains a cautious investment, according to Zuanic & Associates, despite its solid balance sheet and diverse global assets. With a "Neutral" rating, Zuanic views Tilray as a long-term player in the cannabis sector, though short-term uncertainties cloud its outlook....